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Purpose: Peritoneal tissue healing is characterized by the simultaneous repopulation of mesothelial cells
and the formation of neoperitoneum. Despite the common use of mesh products for abdominal wall
repair, there are few investigations of how these materials may impact the peritoneal healing process.
Here, we utilized an animal model of abdominal trauma to speciﬁcally investigate the peritoneal healing
process in conjunction with a composite (poliglecaprone 25-coated polypropylene) mesh.
Methods: Abdominal wall injury was simulated in New Zealand White rabbits and peritoneal tissue was
covered with composite mesh and ﬁxed with peripheral sutures. Animals were sacriﬁced at regular
intervals (up to 28 days) for macroscopic and microscopic evaluation.
Results: Mesothelial cells were consistently identiﬁed on the surface of the central areas of the implanted
mesh as early as 3e5 days after implantation. From day 7 onward, the entire mesh surface was covered
by neoperitoneum which matured over the remaining study intervals. Fibroblast ingrowth of the mesh
was apparent by day 5 and increased over time, concurrent with fragmentation of the ﬁlm on the
composite mesh.
Conclusions: These results suggest that composite mesh products used for abdominal wall repair do not
signiﬁcantly delay mesothelial repopulation. Study results also support the hypothesis that mesothelial
cells involved in healing are derived, at least in part in this model, from free-ﬂoating precursor cells
located within the peritoneal cavity.
© 2015 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The peritoneum is a specialized membrane consisting of a layer
of loose connective tissue and a continuous layer of mesothelialnd Gynecology, University of
eles, CA 90033, United States.
.com (G. diZerega).
Ltd on behalf of IJS Publishing Grcells [1]. The peritoneum is rich in blood vessels, lymphatics and
mesenchymal cells and is connected to the underlying tissue by
subserous tissue which contains elastin and fat cells (primarily in
the greater omentum). The peritoneum provides physical separa-
tion of the abdominal contents from the body wall and minimizes
friction of the abdominal viscera.
The healing process of the peritoneum differs signiﬁcantly from
that of the skin and other epithelial surfaces. Unlike the skin, whichoup Limited. This is an open access article under the CC BY-NC-ND license (http://
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contraction processes, the entire surface of traumatized perito-
neum is simultaneously repopulated with mesothelial cells. It is
widely accepted that the time required for regeneration of the
mesothelial layer is approximately ﬁve to six days [2,3]. However,
the source of cells involved in re-epithelialization remains contro-
versial. Some investigators have suggested that undifferentiated
precursor cells in the subserosal connective tissue populate the site
of injury [2,4,5]. Other investigators have suggested that free-
ﬂoating mesothelial cells implant on and contribute to the repo-
pulation of an injured peritoneal surface [6e9].
Although a large variety of synthetic mesh products with
absorbable barrier components are now available, data is limited
with these devices regarding early peritoneal healing. In the pre-
sent study, we investigated the process of peritoneal healing over
time following tissue injury in a preclinical model using a com-
posite polypropylene mesh with a transparent coating (poligle-
caprone 25) designed to minimize the formation of adhesions. This
was a descriptive evaluation with no treatment comparison;
therefore, the absoluteminimumnumber of animals was utilized to
support the study.
2. Materials and methods
2.1. Animals and care
All animal protocols were approved by the appropriate institu-
tional animal care and use committees and followed the guidelines
established by the Care and Use of Laboratory Animals (NIH pub-
lication 85-23), andmet or exceeded the Johnson& Johnson Animal
Care and Use Guidelines.
2.2. Evaluation of early tissue integration
Implantation, necropsy, and sample collection were conducted
at an independent contracting facility (North American Science
Associates, Incorporated, Northwood, OH) strictly following the
approved protocol and the standard operating procedures. The
necropsies and tissue collection were conducted by the surgeon
who implanted the mesh. One of the authors, who served as the
study pathologist (TM) was present at the necropsies, but did not
contribute to the evaluations or the resulting macroscopic report.
All components of the signed report were reviewed and discussed
by all of the authors with additional review of the macroscopic and
microscopic ﬁndings.
Nine healthy female New Zealand White (NZW) rabbits were
acclimated to Elizabethan (E) collars prior to study onset. In each
animal, a ventral midline incision was made from just caudal of the
xiphoid to just cranial of the pubis. An abdominal wall peritoneal
defect approximately 2 cm  4.5 cm was created along one side of
the animal as far caudal and lateral as possible using sharp
dissection. The peritoneal defect was abraded to induce consistent
punctate bleeding between defect sites and animals. The defect site
was completely covered by a 3 cm 5 cm piece of mesh (ETHICON
PHYSIOMESH™, ETHICON, Inc., Somerville, NJ). Mesh was attached
to the abdominal wall using size 4-0 Prolene Polypropylene Suture
(ETHICON, Inc., Somerville, NJ) in a simple continuous pattern
around the periphery. Once the implant procedure was completed
for one side of the animal, the same procedure was conducted on
the contralateral side. The laparotomies were closed using standard
surgical technique. Rabbits were ﬁtted with E-collars and moni-
tored twice daily for the ﬁrst ﬁve days post-surgery and then daily
until assigned termination intervals. Two animals were sacriﬁced at
3, 5, and 7 days post-implantation and one animal was sacriﬁced at
14, 21, and 28 days post-implantation. Adhesion formation andmacroscopic alterations, if present, were recorded at necropsy. The
implant sites with adjacent tissues were collected and immersed in
10% neutral buffered formalin (NBF). Implantation, necropsy, and
sample collection were conducted at an independent contracting
facility, North American Science Associates, Incorporated, North-
wood, OH. Once adequately ﬁxed, samples were submitted to
Veterinary Pathology Services, Incorporated, Mason, OH, for trim-
ming, soft resin-based tissue processing, and staining with hema-
toxylin and eosin (HE). Soft-resin histology processing was utilized
to reduce artifacts associated with parafﬁn ﬁxation techniques.
Following the protocol and standard operating procedures, a single
section through the short axis was carefully trimmed from each
tissue sample. The short axis was used to minimize the potential
disruption of the implant site during the trimming process. This
was particularly critical for the very early study intervals where the
mesh was just beginning to become integrated with the adjacent
tissues. Each trimmed section underwent standard soft-resin his-
tologic processing. Soft-resin processing was chosen to limit the
tissue processing artifacts that were observed in parafﬁn-based
tissue sections from previous studies and because such process-
ing does not suffer the loss of resolution that is observed with hard-
resin tissue sections.
Stained tissue sections were submitted to the study pathologist
who prepared an independent report directly to the contract lab-
oratory. The entire section from each implant site was examined
(four sections available for 3-, 5-, and 7-day study intervals and two
tissue sections for the 14-, 21-, and 28-day study intervals); only the
ﬁndings from the central area of the tissue section that were devoid
of processing artifacts were reported and used for images. This
method of evaluation limited any potential “edge effects” associ-
ated with the healing processes observed and avoided areas that
were too disrupted by the collection and processing techniques to
be of value. The microscopic evaluation focused upon the assess-
ment of the tissue response, ingrowth, and integration into the
mesh. The amount of tissue response present in the tissue sections
was described using standard pathology terminology deﬁned as
follows: minimal-tissue response just discernible, mild-tissue
response becoming a prominent feature of the tissue section,
moderate-the tissue reaction was a prominent component present
and biologically relevant, and severe-tissue response was a domi-
nant component present and considered a signiﬁcant adverse
ﬁnding. Tissue ingrowth (deﬁned as the amount of immature or
mature ﬁbrous tissue that penetrated into and through the site of
mesh implantation) was described as none, poor (inconsistent or
limited penetration of the article by individual cells or ﬁne strands
of ﬁbroplasia or ﬁbrous tissue), fair (multifocal-to-diffuse pene-
tration of the article by individual cells or ﬁne bands of ﬁbroplasia
or ﬁbrous tissue), good (consistent deep penetration of the article
by bands of ﬁbroplasia or ﬁbrous tissue) or excellent (article
completely penetrated bands of ﬁbroplasia or ﬁbrous tissue). The
tissue integration associated with the mesh was subjectively
described as none, minimal (articleetissue interface consisting
primarily of inﬂammatory cells or ﬂuid accumulation), fair (multi-
focal areas where the articleetissue interface consisting mostly of
ﬁbroplasia or ﬁbrous tissue admixed with low levels of inﬂamma-
tory cells), good (articleetissue interface consisting mostly of
ﬁbroplasia or ﬁbrous tissue) or excellent (article completely inte-
grated with tissue by ﬁbroplasia or ﬁbrous tissue).
2.3. Evaluation of adhesion formation
Fifteen NZW rabbits had similar surgical procedures as
described above except the defect sites were just less than
2.0 cm  4.5 cm to facilitate complete coverage by 2.0 cm  4.5 cm
pieces of mesh, and the adjacent cecum was abraded using dry
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inal wall defects. Five animals were evaluated at 7, 14, and 28 days
post-implantation.
At necropsy, adhesion formation was evaluated using the
following grading scale:
Extent e estimated extent of mesh surface involved in the
adhesion:
0 ¼ no adhesions,
1 ¼ 1e25% of mesh involved,
2 ¼ 26e50% of mesh involved,
3 ¼ 51e75% of mesh involved, and
4 ¼ 76e100% of mesh involved.
Severity e strength of the adhesion:
0 ¼ no adhesion,
1 ¼ adhesion tore with minimal effort,
2 ¼ adhesion tore with moderate effort, and
3 ¼ adhesion required sharp dissection.
The size of themesh at necropsy was compared to the size of the
mesh at the time of implantation to determine the percent of mesh
compression or “shrinkage” over time. Sections of the implant sites
were processed in parafﬁn for histological evaluation after adequate
ﬁxation in 10% NBF. The tissue response to the composite mesh was
semi-quantitatively graded at each study interval. The tissue
response was also characterized by the primary cell type present.
3. Results
No animals had treatment-related adverse events and no evi-
dence of pain or discomfort was noted during this study.
At necropsy 3e5 days after mesh implantation, areas of the
visceral surface of the mesh were glistening (Fig. 1aeb) and the
entire mesh surface was glistening from day 7 post-implantation
(Fig. 1cef) for all of the animals and implant sites. Microscopi-
cally, at 3 days post-implantation, the glistening areas corre-
sponded to layers of cells along the visceral surface of the mesh in
all of the tissue sections reviewed for the study interval. These cells
were morphologically consistent with mesothelial cells (i.e. squa-
mous morphology with scant eosinophilic cytoplasm, elongated
nuclei) and were indistinguishable from the cells lining the peri-
toneal surfaces distant from the implant/defect sites (Fig. 1a). Cells
resembling or having the morphology of peritoneal macrophages
were not observed along the visceral surface of the mesh at 3 days
post-implantation for any of the tissue sections reviewed. However,
peritoneal macrophages were recognized in addition to the meso-
thelial cells at day 5 post-implantation at all of the implant sites
evaluated. At 7 and 14 days post-implantation, the entire visceral
surface of the mesh was covered by glistening areas of neo-
peritoneum for all of the implant sites assessed, deﬁned micro-
scopically as immature ﬁbrovascular tissue covered by a
mesothelial monolayer. The early neoperitoneum became a thin
organizing tissue layer covered by mesothelium which continued
to mature throughout the remaining study intervals. This neo-
peritoneum corresponded to the glistening surface observed at
necropsy 21 and 28 days post-implantation for all animals evalu-
ated. The early andmaturing neoperitoneum has found at that time
to be integrated (merged) with the ﬁbroplasia and ﬁbrous tissue
that penetrated through the composite mesh as detailed below.
At 3 and 5 days post-implantation, the mesh consisted of poly-
propylene (PP) ﬁlaments completely sandwiched between contin-
uous thin layers of poliglecaprone 25. In the areas of themeshwheremultiple PP ﬁlaments were present as part of the knit construction,
the ﬁlms only covered the outer periphery of the ﬁlaments. This
created small spaces between the ﬁlms which contained low
numbers of red blood cells and a small amount of ﬁbrin at 3 days
post-implantation for all of the implant sites evaluated. At 5 days
post-implantation, this space contained a lownumber of ﬁbroblasts
along with the previously mentioned small accumulations of red
blood cells and ﬁbrin. The ﬁnding of ﬁbroblasts within this space,
even though very limited,was theﬁrst evidence of cellular ingrowth
into the mesh. By 7 days post-implantation, the ﬁlms began to
fragment which was evident at all of the implant sites examined.
Theedges of theﬁlm fragmentswere linedbyﬁbroplasia (equivalent
to granulation tissue), conﬁrming that the ﬁlm fragmentation was
not an artifact of tissue collection or tissue processing. The ﬁbro-
plasia associated with the fragmented ﬁlms extended into and
through the composite mesh completely ﬁlling the previously
mentioned spaces between the ﬁlms. The overall ingrowth noted at
7 days post-implantation warranted a grade of good characterized
by the amount of penetration of the mesh by ﬁbroplasia. By 14 days
post-implantation, the ﬁlm fragmentation and penetration of the
ﬁbroplasia had progressed. The ﬁbroplasia was maturing and the
amount of the ﬁbroplasia established within and through the mesh
was consistently located throughout the article in each implant site
evaluated. At 21 and 28 days post-implantation, the ingrowth into
the composite mesh was well established, mature, and consistent
throughout the mesh.
The integration of the abdominal wall with the mesh was
initially evident at 5 days post-implantation in all animals and in all
implant sites. This consisted of low numbers of ﬁbroblasts directly
adjacent to the PP ﬁlaments within the spaces between the two
ﬁlms in the areas of the knit. By 7 days post-implantation the PP
ﬁlaments were directly associated with low numbers of ﬁbroblasts
and a small number of macrophages and giant cells. The PP ﬁla-
ments of the composite mesh were completely integrated with the
abdominal wall by 14 days post-implantation (in all animals and
implant sites) as shown by the quantity and quality of ﬁbroblasts
adjacent to the PP ﬁlaments and the amount of ingrowth present.
The integration of ﬁlm fragments with the abdominal wall paral-
leled that of the PP ﬁlaments. The fragments embedded inmaturing
ﬁbrous tissue by day 7 and 14 and embedded in mature ﬁbrous
tissue 21 and 28 days post-implantation. There was no evidence of
bridging ﬁbrosis or inﬂammation between PP ﬁlaments, between
ﬁlm fragments or between PP and ﬁlm fragments in this study.
Table 1 summarizes the consistent and biologically relevant ob-
servations regarding tissue integration and the composite mesh
over at the course of this study.
3.1. Adhesions
The average mesh surface area was 100 ± 0%, 117 ± 12%, and
101 ± 2% of the original area at 7,14, and 28 days post-implantation,
respectively. In one animal, a single adhesion was noted between
the visceral surface of the mesh and the omentum at 28 days post-
implantation. Otherwise there were no adhesions to the surface of
the mesh or to the neoperitoneum which formed over the mesh.
Adhesions were noted to the periphery of the mesh involving the
suture and some of these adhesions extended to involve the edges
of the mesh at all study intervals.
No adhesions to the surface of the mesh or to the neo-
peritoneum were noted in this study at necropsy.
4. Discussion
This study provides information about the interactions between
a mesh and peritoneal healing following mesh implantation in a
Fig. 1. Gross morphology and H&E staining study intervals. a) Animal 66734 Left Implant. Glistening of the mesh surface consistent with early mesothelial cell attachment. g)
Animal 66734 Left Implant. Mesothelial cell line the outer surface of the mesh (arrows). b) Animal 66737 Left Implant. Glistening of the mesh surface is consistent with early
mesothelial cell attachment. h) Animal 66737 Left Implant. Few ﬁbroblasts (black arrows) are located between the ﬁlaments and the ﬁlm and between ﬁlaments. The outer surface
is covered by mesothelium (white arrows). Processing artifacts are present including separation of the mesh from the underlying tissue and segmental loss of mesothelial covering.
c) Animal 66729 Left Implant. Glistening of the mesh surface is consistent with early mesothelial cell attachment and formation of a neoperitoneum. i) Animal 66729 Left Implant.
More ﬁbroblasts are within the mesh penetrating through breaks in the ﬁlms and the covering mesothelial surface (neoperitoneum) is more mature than in the previous study
intervals processing artifacts are present including separation of the mesh from the underlying tissues and segmental loss of the mesothelial covering. d) Animal 66731 Left Implant.
Glistening of the mesh surface is consistent with early mesothelial cell attachment and formation of a neoperitoneum. j) Animal 66731 Left Implant. More breaks in the ﬁlms were
present with ﬁbroblasts streaming into and through the mesh. The outer surface has well established mesothelial layer (neoperitoneum) of the mesh. e) Animal 66732 Left Implant.
The mesh is covered by tissue. k) Animal 66732 Left Implant. The mesh is completely incorporated and integrated with the underlying tissues. The ﬁlm components of the mesh are
fragmented. f) Animal 66733 Left Implant. The mesh is covered by tissue. l) Animal 66733 Left Implant. The mesh is completely incorporated and integrated with the underlying
tissue. The ﬁlm components of the mesh are fragments.
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3 Individual and conﬂuent groups of cells deposit along visceral surface of the
composite mesh.
Cells morphologically consistent with mesothelial cells.
No accumulations of neutrophils, surgical trauma resolving.
Mesh ﬁlms intact.
Low numbers of red blood cells and a small amount of ﬁbrin observed in
spaces between ﬁlms in areas containing multiple polypropylene
ﬁlaments.
No accumulations of neutrophils.
5 Individual and groups of cells consistently located along the visceral surface
of the composite mesh.
Cells morphologically consistent with mesothelial cells and peritoneal
macrophages.
No accumulations of neutrophils, surgical trauma resolving.
Mesh ﬁlms intact.
Low numbers of red blood cells, ﬁbrin, and very limited numbers of
ﬁbroblasts observed in spaces between ﬁlms.
No accumulations of neutrophils.
7 Thin layer of ﬁbroplasia covered by mesothelial cells established along
visceral surface of the composite mesh (early neoperitoneum).
No accumulations of neutrophils, surgical trauma resolving.
Mesh ﬁlms fragmented.
Fragments lined by ﬁbroplasias.
Fibroplasia extends through composite mesh merging with
neoperitoneum and the parietal surface.
Mesh ﬁlaments beginning to integrate with ﬁbroplasia.
No accumulations of neutrophils.
14 The thin layer of ﬁbroplasia covered by mesothelial cells remodeling
(maturing neoperitoneum).
No foreign body granuloma present.
Mesh ﬁlms associated with increased fragmentation
Fibroplasia established throughout composite mesh extending from
neoperitoneum to the parietal surface
The ﬁbroplasia remodeling and maturing
Mesh ﬁlaments completely integrated with ﬁbroplasia.
21 Fibrous tissue established along visceral surface of the composite mesh
completely covered by mesothelial cells (mature neoperitoneum).
No foreign body granuloma present.
Mesh ﬁlms completely fragmented
Fibroplasia matured into ﬁbrous tissue.
Fibrous tissue merges with neoperitoneum and parietal tissues.
Mesh ﬁlaments completely integrated with surrounding tissues.
28 Mature peritoneum consisting of remodeling ﬁbrous tissue covered by a ﬂat
sheet of mesothelial cells.
No foreign body granuloma present.
Mesh ﬁlms fragmented.
Fibrous tissue extends completely through composite mesh form the
parietal surface to the neoperitoneum.
Mesh ﬁlaments completely integrated with tissues.
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were necessary because of the descriptive nature of the study, the
simple study design (no treatment comparisons), and the consis-
tency of the observations.
The presence of mesothelial cells and the formation of early
neoperitoneum are known to be crucial for preventing adhesions
during peritoneal healing following surgical injury [1e3,7e11]. In
the current study, the process of peritoneal healing was evaluated
in the context of a composite mesh designed to minimize the for-
mation of adhesions. Presumptive mesothelial cells were observed
along the visceral surface of the composite mesh as early as 3 days
post-implantation and complete coverage by neoperitoneum was
observed at 7 days post-implantation. This early observation of
mesothelial cells supports Mutsaers' study that conﬁrmedmaximal
DNA synthesis in the surrounding mesothelial cell population 48 h
after injury [11]. Importantly, this early neoperitoneum was inte-
grated with the underlying composite mesh by 7 days post-
implantation and had matured between 14 and 21 days. Integra-
tion and ingrowth were demonstrated to start 5 days post-
implantation and were well-established by 14 days post-
implantation. This observation is consistent with the kinetics of
peritoneal healing and mesothelial deposition in the absence of a
mesh [1e3]. Based on these results, it would seem unlikely that the
early mesothelial cells migrated from the subserosal layer, as the
ﬁlm barrier had no evidence of fragmentation at the early time
points when mesothelial cells were present on the surface of the
mesh and were coming to conﬂuence. It was unlikely that the
mesothelium was the result of migration from the edges since the
mesothelial cells were located away from the mesh edges. These
results are more consistent with the hypothesis that the early
neoperitoneum is formed, at least in part, by free-ﬂoating meso-
thelial cells resident within the peritoneal cavity. This conclusion is
in agreement with that of Foley-Comer et al. [6]. In their study,cultured mesothelial cells, ﬁbroblasts and peritoneal lavage cells
were ﬂuorescently labeled and injected into Wistar rats immedi-
ately after inducing mesothelial injury with a thermal probe. Using
confocal microscopy, pre-labeled mesothelial cells and peritoneal
lavage cells were found to implant on the wound surface and
proliferate, while ﬁbroblasts failed to attach. Colocalization studies
further demonstrated that, althoughmacrophages in the peritoneal
lavage attached to the wound surface, they were not present in
association with the healed mesothelium [6].
Overall, the tissue response to the implanted mesh was within
the expected and acceptable range for a mesh and the time post-
implantation. In a recent study reporting the results of similar
study using scanning electron microscopy the authors were able to
demonstrate that two weeks following peritoneal damage and
application of an adhesion barrier the injured surface was covered
by ﬁbers and mesothelial cells to different degrees, depending on
the barrier used [12]. In the present study majority of the cells
involved were macrophages and giant cells with no indication of a
suppurative response. The tissue response appeared to resolve over
the course of the study as the procedural trauma resolved. Perito-
neal macrophages are also components of normal peritoneal
healing [1,3,4,8,9,11,13]. These cells were identiﬁed along the
visceral surface of the mesh 5 days post-implantation. Peritoneal
macrophages were not identiﬁed by histological evaluation at day 3
post-implantation. However, inherent limitations of tissue ﬁxation
and processing may have resulted in loss of loosely-adherent
macrophages at this early time point. Interpretation of the histol-
ogy would have been enhanced with the use of immunohisto-
chemical technics to more fully characterize the primitive
mesothelial cells. However, these studies were not performed due
to requirements for plastic embedding.
The results of this study suggest that peritoneal healing over a
compositemesh closelymimics that of injured tissue in the absence
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described hereinmay not apply to all mesh devices ormaterials. For
example, when a polyethylene sheet was placed over a peritoneal
injury, the surface was found to be covered by macrophages with
only a small number of ﬁbroblasts or mesothelial cells [2]. The
poliglecaprone 25 ﬁlms in the current mesh begin to fragment in
situ starting at 5 and 7 days post-implantation, most likely due to
movement and/or some early loss of structural integrity. This
fragmentation of the ﬁlms may facilitate cellular ingrowth and
tissue integration while permitting the surface attachment of
mesothelial cells and neoperitoneum formation consistent with
adhesion prevention.
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